Core Laboratories Inc

Research Core Laboratories Inc (CLB) on Bullrun: valuation model: 40.1% undervalued, market cap USD 503.38M, P/E 16.5, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerCLB
ExchangeNYSE
CountryUnited States
SectorEnergy
IndustryOil & Gas Equipment & Services
CurrencyUSD
Valuation signal40.1% undervalued
Market capUSD 503.38M
P/E16.5
Dividend yield0.4%
Financial periodFY2025
RevenueUSD 526.52M
Revenue growth0.5%
Net incomeUSD 29.67M
Free cash flowUSD 25.82M
Gross margin20.7%

Valuation Snapshot

Bullrun's latest valuation model marks Core Laboratories Inc as 40.1% undervalued; latest market cap is USD 503.38M; P/E is 16.5; dividend yield is 0.4%.

About Core Laboratories Inc

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs.

Frequently asked questions

Is Core Laboratories Inc overvalued or undervalued?

Bullrun's valuation model currently marks Core Laboratories Inc as 40.1% undervalued.

What is Core Laboratories Inc's market cap?

Core Laboratories Inc's market capitalization is USD 503.38M.

What is Core Laboratories Inc's P/E ratio?

Core Laboratories Inc's price-to-earnings (P/E) ratio is 16.5.

Does Core Laboratories Inc pay a dividend?

Core Laboratories Inc has a dividend yield of 0.4%.